Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes;Influencia del síndrome metabólico en el riesgo cardiovascular de pacientes con diabetes tipo 2

Revista Espanola de Cardiologia

Volumn 57, Issue 6, 2004, Pages 507-513

  Gimeno Orna, José A ^a,b   Lou Arnal, Luis M ^a   Molinero Herguedas, Edmundo ^a   Boned Julián, Beatriz ^a   Portilla Córdoba, Desirée P ^a  

^a Hospital de Alcañiz Alcañiz   (Spain)

^b NONE   (Spain)

Author keywords

Coronary heart disease; Diabetes mellitus; X syndrome

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CALCULATION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LEG AMPUTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STROKE; TRANSIENT ISCHEMIC ATTACK; WORLD HEALTH ORGANIZATION; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; INCIDENCE; MIDDLE AGED; PREDICTION AND FORECASTING; RISK FACTOR;

AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 3242879541     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13062916     Document Type: Article

References (28)

1. Lotufo PA, Gaziano JM, Chae CU, Ajani UA, Moreno-John G, Buring JE, et al. Diabetes and all cause coronary heart disease mortality among US male physicians. Arch Intern Med 2001;161: 242-7.
2. Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women. Arch Intern Med 2001;161:1717-23.
3. Esmatjes E, Vidal J. Patología cardíaca de origen extracardíaco. Repercusiones cardíacas de la diabetes mellitus. Rev Esp Cardiol 1998;51:661-70.
4. Barrett Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991;265:627-31.
5. Bierman EL. Atherogenesis in diabetes. Arterioscler Thromb 1992;12:647-56.
6. Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Diabetes Care 2002;25:1135-41.
7. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 1998;20:157-72.
8. Alberti KG, Zimmet PZ, for the WHO Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
9. World Health Organization Study Group on Diabetes Mellitus. Technical report series 727. Geneva: WHO, 1985.
10. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.
11. Bonora E, Kiechl S, Willeit J, Oberhollonzer F, Egger G, Targher G, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998;47:1643-9.
12. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288:2709-16.
13. Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia 2000;43:148-55.
14. Isomaa B, Henricsson M, Almgren P, Tuomi T, Taskinen MR, Groop L. The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia 2001;44:1148-54.
15. Magro-López AM, Molinero de Miguel E, Saéz-Meabe Y, Narváez-Gofinondo I, Saéz de Lafuente-Chivite JP, Sagastagoitia-Gorostiza JD, et al. Prevalencia de los principales factores de riesgo cardiovascular en mujeres de Vizcaya. Rev Esp Cardiol 2003;56:783-8.
16. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovas J, Cordón F, et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol 2003;56:253-61.
17. Verdecchia P, Angeli F. Séptimo informe del Joint National Committee Para la Prevención, Detección, Evaluación y Tratamiento de la Hipertensión Arterial: el armamento está a punto. Rev Esp Cardiol 2003;56:843-7.
18. González-Juanatey JR, Mazón-Ramos P, Soria-Arcos F, Barrios-Alonso V, Rodriguez-Padial L, Bertomeu-Martinez V. Actualización (2003) de ]as Guías de Práctica Clínica de la Sociedad Española de Cardiología en hipertensión arterial. Rev Esp Cardiol 2003;56:487-97.
19. Rodriguez BL, Curb JD, Burchfiel CM, Huang B, Sharp DS, Lu GY, et al. Impaired glucose tolerance, diabetes and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program. Diabetes Care 1996;19:587-90.
20. Lehto S, Ronnemaa T, Haffner S, Pyorala K, Kallio V, Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle aged patients with NIDDM. Diabetes 1997;46: 1354-9.
21. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44.
22. Van Gaal L, Rillaerts E, Creten W, De Leeuw I. Relationship of body fat distribution pattern to atherogenic risk factors in NIDDM: Preliminary results. Diabetes Care 1988;11:103-6.
23. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non insulin dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997;157: 1413-8.
24. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ. Urinary albumin excretion, cardiovascular disease and endothelial dysfunction in non insulin dependent diabetes mellitus. Lancet 1992;340:319-23.
25. Wollesen F, Berglund L, Berne C. Insulin resistance and atherosclerosis in diabetes mellitus. Metabolism 2002;51:941-8.
26. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
27. Birkeland KI, Kilhovd B, Thorsby P, Torjesen PA, Ganss R, Vaaler S, et al. Heterogeneity of non insulin dependent diabetes expressed as variability in insulin sensitivity, beta cell function and cardiovascular risk profile. Diabet Med 2003;20:37-45.
28. Marrugat J, Zamora A. Pronóstico de los pacientes diabéticos con cardiopatía isquémica. Rev Esp Cardiol 2002;55:751-62.